MENU
+Compare
ADIL
Stock ticker: NASDAQ
AS OF
Jul 21, 01:23 PM (EDT)
Price
$0.47
Change
+$0.02 (+4.44%)
Capitalization
7.12M

ADIL Adial Pharmaceuticals Forecast, Technical & Fundamental Analysis

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADIL with price predictions
Jul 18, 2025

Momentum Indicator for ADIL turns positive, indicating new upward trend

ADIL saw its Momentum Indicator move above the 0 level on July 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 108 similar instances where the indicator turned positive. In of the 108 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ADIL's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ADIL just turned positive on June 30, 2025. Looking at past instances where ADIL's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ADIL advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADIL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ADIL broke above its upper Bollinger Band on July 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ADIL entered a downward trend on June 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.347) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). ADIL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.975).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADIL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADIL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ADIL is expected to report earnings to fall 82.35% to -5 cents per share on August 15

Adial Pharmaceuticals ADIL Stock Earnings Reports
Q2'23
Est.
$-0.06
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.05
Q1'23
Est.
$-0.10
Q4'22
Beat
by $0.05
The last earnings report on May 14 showed earnings per share of -34 cents, beating the estimate of -38 cents. With 926.33K shares outstanding, the current market capitalization sits at 7.12M.
A.I. Advisor
published General Information

General Information

a developer of medications to treat addiction and related disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
4870 Sadler Road
Phone
+1 804 487-8196
Employees
7
Web
https://www.adialpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.060.03
+1.48%
GT Biopharma
BURL265.403.14
+1.20%
Burlington Stores
BMEA1.85-0.06
-3.14%
Biomea Fusion
SLVM48.86-1.67
-3.30%
Sylvamo Corp
EXK5.38-0.19
-3.41%
Endeavour Silver Corp

ADIL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with VANI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+11.41%
VANI - ADIL
37%
Loosely correlated
-4.32%
CLYM - ADIL
34%
Loosely correlated
+3.42%
GDTC - ADIL
30%
Poorly correlated
-0.33%
VTVT - ADIL
28%
Poorly correlated
+3.77%
JAGX - ADIL
26%
Poorly correlated
N/A
More